Essential Updates: Comp Medical News for October
Welcome to this month’s edition of Comp Medical News. FDA’s refusal to approve a new opioid, poor sleep’s effect on chronic pain, and $8,000 pain creams are your headlines for October 2017.
Welcome to this month’s edition of Comp Medical News. FDA’s refusal to approve a new opioid, poor sleep’s effect on chronic pain, and $8,000 pain creams are your headlines for October 2017.